MENU
VACBF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

NYKODE THERAPEUTICS AS (VACBF) Ownership - Who owns NYKODE THERAPEUTICS AS?

Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies... Show more

Profile

Industry
N/A
Address
Gaustadalleen 21
Phone
+47 22958193
Employees
155
Web
https://www.nykode.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
76.17M
P/E Ratio
N/A
Total Cash
63.93M
Projected Growth
N/A
Total Debt
2.9M
Revenue
6.77M
Risk (Beta)
N/A
Dividend Yield
0.53
Total Cash/Share
0.20
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price

Fundamentals

VACBF
Capitalization
76.2M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
0.53
Total Cash
63.9M
Total Cash/Share
0.20
Total Debt
2.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
6.77M
ROE
N/A
Book Value
99.3M
P/B Ratio
0.62
Cash Flow
N/A
Earnings
-0.03
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
367K
Current Ratio
17.14
Current Revenue Per Employee
48726.62
Dividends Per Share - Security
0.00
EBITDA
-14.42M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-8.03
Shares Held By Institutions
39.7M
Shares Outstanding - Current
327M
Total Liabilities
6.45M
Total Volume MTD
N/A
Value
1
Gain YTD
-21.927
View a ticker or compare two or three
VACBF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Gaustadalleen 21
Phone
+47 22958193
Employees
155
Web
https://www.nykode.com